Ignite Creation Date:
2024-05-05 @ 11:39 PM
Last Modification Date:
2024-10-26 @ 10:37 AM
Study NCT ID:
NCT01389206
Status:
COMPLETED
Last Update Posted:
2018-08-15
First Post:
2011-07-06
Brief Title:
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Sponsor:
Actelion
Organization:
Actelion
Study Overview
Official Title:
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status:
COMPLETED
Status Verified Date:
2018-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PAH QuERI Ext
Brief Summary:
Knowledge Translation Program for the guidelines and evidence-based management of PAH patients
Detailed Description:
To improve the management of PAH patients through an evidence-based approach aimed at achieving optimal WHO functional class defined as 1 improvement of FC III or IV to FC II 2 improvement of FC II to FC I or 3 maintaining FC II or I
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None